Clinical Trials Browser

Phase 3 × Carcinoma, Ovarian Epithelial × apatinib × Clear all

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Phase 3 Not yet recruiting

Carcinoma, Ovarian Epithelial